Eosinophilic airway inflammation and eosinophilic chronic rhinosinusitis during nivolumab and ipilimumab-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Eosinophilic airway inflammation and eosinophilic chronic rhinosinusitis during nivolumab and ipilimumab

Published:2020-07-30 Issue:7 Volume:8 Page:
ISSN:2051-3380
Container-title:Respirology Case Reports
language:en
Short-container-title:Respirology Case Reports

Author:

Watanabe Hirofumi¹^ORCID,Asada Kazuhiro¹,Shirai Toshihiro¹^ORCID,Torii Hiroko²,Yoshimura Koji³,Kusafuka Kimihide⁴

Affiliation:

1. Department of Respiratory Medicine Shizuoka General Hospital Shizuoka Japan

2. Department of Otorhinolaryngology, Head and Neck Surgery Shizuoka General Hospital Shizuoka Japan

3. Department of Urology Shizuoka General Hospital Shizuoka Japan

4. Department of Pathology Shizuoka General Hospital Shizuoka Japan

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/rcr2.638

Reference6 articles.

1. Novel scoring system and algorithm for classifying chronic rhinosinusitis: the JESREC Study

2. B7-DC Regulates Asthmatic Response by an IFN-γ-Dependent Mechanism

3. Blockade of CTLA-4 enhances allergic sensitization and eosinophilic airway inflammation in genetically predisposed mice

4. Costimulation through B7-2 (CD86) Is Required for the Induction of a Lung Mucosal T Helper Cell 2 (TH2) Immune Response and Altered Airway Responsiveness

5. Nose and lungs: one way, one disease

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immune Checkpoint Inhibitor (ICI) Induced Sinonasal Disease: Review of Literature and FDA Database;Annals of Otology, Rhinology & Laryngology;2024-08-08

2. Nivolumab Therapy in Lung Cancer Associated with IgG4-related Disease;Internal Medicine;2024-01-15

3. Pembrolizumab-Induced Nasal Polyposis: The First Reported Case;Journal of Rhinology;2023-07-31

4. Airway disorders associated with immune checkpoint inhibitor therapy: Two case reports and a systematic review;Seminars in Oncology;2022-12

5. Nivolumab-associated Nasal Polyposis and Eosinophilic Asthma Responsive to Benralizumab, An Anti-IL5R Biologic;Journal of Immunotherapy;2022-08-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3